Science Times Observer: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Times Observer.

Press releases published on September 9, 2026

Sep. 9, 2026

Hudbay Recognized as a Top Performer by the Toronto Stock Exchange with Inclusion in the TSX30

Indeterminate GlobeNewswire

Sep. 9, 2026

Rail Vision Introduces TrackScout and YardFlow Flex as New Brand Names for its Mainline and Switchyard Solutions

Indeterminate GlobeNewswire

Sep. 9, 2026

NervGen to Host Inaugural R&D Day on September 30, 2026

Indeterminate GlobeNewswire

Sep. 9, 2026

Context Therapeutics Announces First Patient Dosed in Phase 1 Trial of CT-202

Indeterminate GlobeNewswire

Sep. 9, 2026

Avicanna Launches MyMedi.ca Integrated Healthcare Program in Canada

Indeterminate GlobeNewswire

Sep. 9, 2026

XCharge Regains Compliance with Nasdaq Minimum Bid Price Requirement

Indeterminate GlobeNewswire

Sep. 9, 2026

Telesat named to the TSX30, ranking among the top performing stocks on the Toronto Stock Exchange

Indeterminate GlobeNewswire

Sep. 9, 2026

Gilat Awarded Over $32 Million for Multi-Band DKET Systems Supporting U.S. Defense Network Resilience

Indeterminate GlobeNewswire

Sep. 9, 2026

CRB Names Helga Margrethe Salling Chief Growth Officer

Indeterminate GlobeNewswire

Sep. 9, 2026

Kane Biotech to Host Commercial Update Webcast on September 16

Indeterminate GlobeNewswire

Sep. 9, 2026

Bilibili Inc. Announces Completion of US$500 Million Marketed Convertible Senior Notes Offering, Concurrent Equity Placement and Concurrent Delta Repurchase

Indeterminate GlobeNewswire

Sep. 9, 2026

U.S. Critical Minerals enters into agreements to merge with Nova Resources and acquire the historic McAllister tantalum mine and mill in Alabama

Indeterminate GlobeNewswire

Sep. 9, 2026

Balchem Corporation to Participate in the 9th Annual Wells Fargo Consumer Conference on September 23, 2026

Indeterminate GlobeNewswire

Sep. 9, 2026

Remix Therapeutics Appoints Nicole Sweeny as Chief Commercial Officer

Indeterminate GlobeNewswire

Sep. 9, 2026

Accumulus Technologies Announces Acquisition by Eir Partners to Accelerate Next Phase of Growth

Indeterminate GlobeNewswire

Sep. 9, 2026

Satellos Announces Forazapadin as Assigned International Nonproprietary Name for Lead Drug Candidate, SAT-3247

Indeterminate GlobeNewswire

Sep. 9, 2026

SailPoint Announces Fiscal Second Quarter 2027 Results

Indeterminate GlobeNewswire

Sep. 9, 2026

Autolus Therapeutics Announces FDA RMAT Designation Granted to Obe-cel for the Treatment of Systemic Lupus Erythematosus and Lupus Nephritis

Indeterminate GlobeNewswire

Sep. 9, 2026

Onco360® Has Been Selected as Part of an Ultra-Narrow Specialty Pharmacy Network for MIMRYLO™ (rusfertide)

Indeterminate GlobeNewswire

Sep. 9, 2026

Aldebaran Reports 513 m of 1.06% CuEq (1.01% Cu, 0.08 g/t Au & 3.58 g/t Ag), Within 1,257.30 m of 0.66% CuEq (0.62% Cu, 0.05 g/t Au & 1.94 g/t Ag) at the Altar Copper-Gold Project in San Juan, Argentina

Indeterminate GlobeNewswire